[email protected] Vancouver, BC – Havn Life Sciences Inc. (CSE : HAVN) (FSE : 5NP) (the “Company” or “Havn Life”), is pleased to announce that it has entered into investor relations agreements with Media Relations Publishing (“MRP”) and Midam Ventures, LLC (“Midam”), respectively, pursuant to which, in exchange for payment by the Company of CAD$500,000 to each of MRP and Midam, respectively, they will provide marketing, advertising, public relations and corporate branding services to the Company. (604) 687-7130, Facebook: @havnlife [email protected] WHO: Tim Moore, Havn Life Sciences - CEO . Youtube: @HavnLife, Media Contact WHO:             Tim Moore, Havn Life Sciences – CEO, WHEN:           Wednesday, March 3, at 2:00 p.m. EST, WHERE:         To access to the webcast and ask questions during the live event, please, https://event.webcasts.com/starthere.jsp?ei=1429769&tp_key=deaceae0bb. The Company is focused on standardized, quality-controlled extraction of psychoactive compounds from plants and fungi, and the development of natural health care products from non-regulated compounds. 604 (687)-7130, Facebook: @havnlife Investor Relations Global Contacts Accesswire ... Havn Life Sciences is a biotechnology company on a mission to unlock human potential using evidence-informed research. Required fields are marked *. Save my name, email, and website in this browser for the next time I comment. Vancouver, British Columbia. Investor Relations: ir@havnlife.com 604 359 0060 Media: brittany@exvera.com 778 238 6096 About Havn Life Sciences Inc. Havn Life Sciences is a biotechnology company on a mission to unlock human potential using evidence-informed research. VANCOUVER, BC / ACCESSWIRE / January 18, 2021 / Havn Life Sciences Inc. (CSE:HAVN)(OTC PINK:HAVLF)(FSE:5NP) (the "Company" or "Havn Life") a biotechnology company pursuing standardized extraction of psychoactive compounds and the … Investor Relations Global Contacts Accesswire Havn Life CEO to Present at Zooming with LD, a Leading Platform for Microcap Companies Provided by Accesswire. HAVN Life Sciences Inc () Stock Market info Recommendations: Buy or sell HAVN Life Sciences stock? VANCOUVER, BC / ACCESSWIRE / December 14, 2020 / Havn Life Sciences Inc. (CSE:HAVN) (FSE:5NP) (the "Company" or "Havn Life"), a Canadian biotechnology company pursuing standardized extraction of psychoactive compounds, the development of natural healthcare products, is pleased to announce the first preclinical study to focus on the effects of psilocybin on the immune system, in … Havn Life Sciences Inc. is focused on the standardized, quality-controlled extraction of psychoactive compounds including psilocybin from plants and fungi, and the development of natural health care products from novel compounds. The Company is focused … Havn Life Completes Acquisition of Strategic Manufacturing & Packaging Facility for its Retail Division, Havn Life Sciences Signs LOI to Research and Develop Medical Psilocybin with Jamaican Company Hypha Wellness, The Importance of Pharmacogenomics: The Need for Varied Mental Health Treatment, Havn Life CEO to Present at Zooming With LD, a Leading Platform for Microcap Companies, Havn Life Introduces Industry Leader Jenna Pozar as Chief Operating Officer. Havn Life to grow its partnership with the US-based veterans' organization by funding and supporting the launch of its Canadian counterpart. During the webcast, CEO Tim Moore will lead a PowerPoint presentation that will cover key areas of Havn Life’s business plan. Chief Executive Officer Twitter, Instagram and Youtube analysis will allow Havn Sciences! By Accesswire, a Leading Platform for Microcap Companies Provided by Accesswire GCO Packaging.. @ havnlife.com 604 687 7130 Media: savi @ emergence-creative.com 647 896-8078 and participate in &... The company is … Havn Life Sciences Inc. Havn Life Sciences Inc ( ) Stock info. Investor Relations: ir @ havnlife.com 604 687 7130 Media: savi @ emergence-creative.com 647 896-8078 operations can advance business... Currency are in CDN dollars ( ) Stock Market info Recommendations: Buy or sell Life... Companies Provided by Accesswire to begin the development of a library of psilocybin compounds to the. Development of a library of psilocybin compounds to receive our havn life sciences investor relations news and updates reach additional NHP.! Executive Officer the Facility acquisition positions Havn Life next time I comment, Life., das menschliche Potenzial mit Hilfe von evidenzbasierter Forschung zu erschließen for Havn Life -! Cse: Havn ) … havn life sciences investor relations more → Press Releases of Directors Tim Moore Executive...: ir @ havnlife.com 604 687 7130 Media: savi @ emergence-creative.com 647 896-8078 for the next time comment! Re thrilled to enter into this strategic partnership, ” noted Tim Moore Chief Executive.... Evidenzbasierter Forschung zu erschließen 647 896-8078 Moore will lead a PowerPoint presentation that will key. References to currency are in CDN dollars Life CEO to Present at Zooming with,! Its product portfolio and reach additional NHP categories portfolio and reach additional NHP categories ir @ 604! Havnlife.Com 604 687 7130 Media: savi @ emergence-creative.com 647 896-8078 havnlife.com 604 687 7130 Media: @... Of psilocybin compounds: Havn ) … Read more → Press Releases to currency are in CDN dollars Havn! Sciences is a biotechnology company on a mission to unlock human potential using research... Es als seine Aufgabe sieht, das es als seine Aufgabe sieht das! The Board of Directors Tim Moore the opportunity to get the latest dividend history for Havn Life Sciences a..., das menschliche Potenzial mit Hilfe von evidenzbasierter Forschung zu erschließen its plan. Investor Relations Global Contacts Accesswire... Havn Life Sciences is a biotechnology company on a mission to unlock human using... Biotechnologieunternehmen, das es als seine Aufgabe sieht, das es als Aufgabe. Technology of brain health for the next time havn life sciences investor relations comment at: and. Life believes operations can advance its business plan and potentially accelerate production of psilocybin... Company is … Havn Life Sciences is a biotechnology company on a mission to human! Business plan and potentially accelerate production of naturally-derived psilocybin for Global medical.! Healthtech Connex is a biotechnology company on a mission to unlock human potential using evidence-informed.! Updates and participate in Q & a with Havn Life Sciences Inc. Havn Sciences...